Literature DB >> 27182189

Integrating Genetics and Medicine: Disease-Modifying Treatment Strategies for Hypertrophic Cardiomyopathy.

Carolyn Y Ho1.   

Abstract

Entities:  

Year:  2016        PMID： 27182189      PMCID： PMC4862597          DOI： 10.1016/j.ppedcard.2016.01.007

Source DB:  PubMed          Journal:  Prog Pediatr Cardiol        ISSN： 1058-9813


× No keyword cloud information.
  19 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers.

Authors:  Wessel P Brouwer; Tjeerd Germans; Maaike C Head; Jolanda van der Velden; Martijn W Heymans; Imke Christiaans; Arjan C Houweling; Arthur A Wilde; Albert C van Rossum
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-01-24       Impact factor: 6.875

3.  Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.

Authors:  Tjeerd Germans; Arthur A M Wilde; Pieter A Dijkmans; Wenxia Chai; Otto Kamp; Yigal M Pinto; Albert C van Rossum
Journal:  J Am Coll Cardiol       Date:  2006-11-28       Impact factor: 24.094

4.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 5.  Hypertrophic cardiomyopathy in 2012.

Authors:  Carolyn Y Ho
Journal:  Circulation       Date:  2012-03-20       Impact factor: 29.690

6.  T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.

Authors:  Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 7.792

7.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

Authors:  Christopher Semsarian; Imran Ahmad; Michael Giewat; Dimitrios Georgakopoulos; Joachim P Schmitt; Bradley K McConnell; Steven Reiken; Ulrike Mende; Andrew R Marks; David A Kass; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

8.  A mouse model of familial hypertrophic cardiomyopathy.

Authors:  A A Geisterfer-Lowrance; M Christe; D A Conner; J S Ingwall; F J Schoen; C E Seidman; J G Seidman
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

9.  Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.

Authors:  Gabriella Captur; Luis R Lopes; Timothy J Mohun; Vimal Patel; Chunming Li; Paul Bassett; Gherardo Finocchiaro; Vanessa M Ferreira; Maite Tome Esteban; Vivek Muthurangu; Mark V Sherrid; Sharlene M Day; Charles E Canter; William J McKenna; Christine E Seidman; David A Bluemke; Perry M Elliott; Carolyn Y Ho; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2014-09-16       Impact factor: 7.792

10.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094
View more
  1 in total

1.  Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).

Authors:  Carolyn Y Ho; Sharlene M Day; Euan A Ashley; Michelle Michels; Alexandre C Pereira; Daniel Jacoby; Allison L Cirino; Jonathan C Fox; Neal K Lakdawala; James S Ware; Colleen A Caleshu; Adam S Helms; Steven D Colan; Francesca Girolami; Franco Cecchi; Christine E Seidman; Gautam Sajeev; James Signorovitch; Eric M Green; Iacopo Olivotto
Journal:  Circulation       Date:  2018-08-23       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.